Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia

PHASE4RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Gastric Intestinal Metaplasia
Interventions
DRUG

Weifuchun

Subjects will be instructed to take four tablets (1400mg) of Weifuchun three times daily, and visit the hospital every 4 weeks for evaluation of the subjective symptoms and to receive a new supply of medication.

DRUG

Folic Acid

Subjects will be instructed to take one tablet (5mg) of folic acid three times daily, and visit the hospital every 4 weeks for evaluation of the subjective symptoms and to receive a new supply of medication.

Trial Locations (1)

710032

RECRUITING

Xijing hospital, Xi'an

All Listed Sponsors
lead

Yongquan Shi

OTHER